Mycoplasma Infections of the Human Respiratory Tract
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The knowledge on the role of M. pneumoniae in human respiratory tract infections especially in infants and children has advanced in the past two decades. The understanding of its incidence, clinical presentations, pathology & pathogenesis, laboratory diagnosis, complications and late sequelae, treatment, prevention and epidemiological aspects place it as an important aetiological agent in the pediatric patients. It should be considered in the differential diagnosis of all pneumonias. Further studies are needed to solve many observations on the role of mycoplasma in diseases of man.
References
1.
Biberfeld G, NORBERG R
. Circulating immune complexes in Mycoplasma pneumoniae infection. J Immunol. 1974; 112(1):413-5.
View
2.
Cassell G, Cole B
. Mycoplasmas as agents of human disease. N Engl J Med. 1981; 304(2):80-9.
DOI: 10.1056/NEJM198101083040204.
View
3.
Tully J, Whitcomb R, Clark H, Williamson D
. Pathogenic mycoplasmas: cultivation and vertebrate pathogenicity of a new spiroplasma. Science. 1977; 195(4281):892-4.
DOI: 10.1126/science.841314.
View
4.
GRAYSTON J, ALEXANDER E, KENNY G, CLARKE E, FREMONT J, MACCOLL W
. MYCOPLASMA PNEUMONIAE INFECTIONS. CLINICAL AND EPIDEMIOLOGIC STUDIES. JAMA. 1965; 191:369-74.
DOI: 10.1001/jama.1965.03080050015004.
View
5.
Eng J
. Studies on the complement fixation test with Mycoplasma pneumoniae antigen. 2. Application of the test to hospitalized pneumonia patients and to healthy blood donors. Acta Pathol Microbiol Scand. 1967; 71(2):265-73.
View